|
CN1191273C
(zh)
|
1999-05-17 |
2005-03-02 |
康久化学公司 |
长效促胰岛肽
|
|
US6887470B1
(en)
|
1999-09-10 |
2005-05-03 |
Conjuchem, Inc. |
Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
|
|
US7601691B2
(en)
|
1999-05-17 |
2009-10-13 |
Conjuchem Biotechnologies Inc. |
Anti-obesity agents
|
|
US20030054988A1
(en)
*
|
2000-11-02 |
2003-03-20 |
Weidong-Richard Ji |
Modified plasminogen related peptide fragments and their use as angiogenesis inhibitors
|
|
AU2002233082B2
(en)
|
2001-02-02 |
2005-11-10 |
Conjuchem Biotechnologies Inc. |
Long lasting growth hormone releasing factor derivatives
|
|
WO2002066511A2
(en)
|
2001-02-16 |
2002-08-29 |
Conjuchem Inc. |
Long lasting glucagon-like peptide 2 (glp-2) for the treatment of gastrointestinal diseases and disorders
|
|
WO2002083921A2
(en)
|
2001-04-10 |
2002-10-24 |
Agensys, Inc. |
Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
|
|
US7491702B2
(en)
|
2001-04-18 |
2009-02-17 |
The Open University |
Polypeptides related to amyloid precursor protein, pharmaceutical compositions thereof, and methods of treatment using the same
|
|
GB2391548B
(en)
*
|
2001-04-18 |
2005-11-30 |
Univ Open |
Polypeptides and derivatives thereof related to amyloid precursor protein (APP)
|
|
US20050130902A1
(en)
*
|
2001-05-17 |
2005-06-16 |
Shashoua Victor E. |
Peptide compounds for counteracting reactive oxygen species and free radicals
|
|
JP4235544B2
(ja)
|
2001-05-31 |
2009-03-11 |
アドライフ インコーポレーティッド |
欠陥折畳み蛋白質センサー方法
|
|
DE60216151T2
(de)
|
2001-05-31 |
2007-09-27 |
ConjuChem Biotechnologies Inc., Montreal |
Langwirkende Fusionspeptidinhibitoren gegen HIV-Infektion
|
|
US20050026165A1
(en)
*
|
2001-05-31 |
2005-02-03 |
Cindy Orser |
Detection of conformationally altered proteins and prions
|
|
ES2391551T3
(es)
*
|
2001-10-18 |
2012-11-27 |
Zlatko Ademovic |
Combinación de dos regiones bioactivas de la hormona pro-opiomelanocortina
|
|
US6822073B2
(en)
*
|
2001-12-20 |
2004-11-23 |
Kimberly-Clark Worldwide, Inc. |
Modular peptide-based reagent
|
|
CN1753909A
(zh)
*
|
2002-03-19 |
2006-03-29 |
株式会社康福来 |
肽,含有该肽的药物组合物和用于治疗癌症的药物组合物
|
|
JP2004008027A
(ja)
*
|
2002-06-04 |
2004-01-15 |
Japan Science & Technology Corp |
ｃＡＭＰの産生活性を有する新規ペプチド
|
|
WO2004011595A2
(fr)
*
|
2002-07-26 |
2004-02-05 |
Institut Pasteur |
Vecteurs destines au transfert de molecules d'interet dans des cellules cibles
|
|
AU2003246500A1
(en)
*
|
2002-07-31 |
2004-02-16 |
Conjuchem Biotechnologies Inc. |
Long lasting natriuretic peptide derivatives
|
|
JP5385497B2
(ja)
*
|
2002-09-24 |
2014-01-08 |
フロンティア バイオテクノロジーズ カンパニー リミテッド |
Ｈｉｖ感染のペプチド誘導体融合阻害剤
|
|
US7378495B2
(en)
*
|
2002-10-21 |
2008-05-27 |
Pevion Biotech, Ltd. |
PTH-rP related peptide cancer therapeutics
|
|
AU2003290563A1
(en)
*
|
2002-10-31 |
2004-05-25 |
Clf Medical Technology Acceleration Program, Inc. |
Leptin-related peptides
|
|
CA2504953C
(en)
*
|
2002-11-07 |
2013-08-20 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
A new target for angiogenesis and anti-angiogenesis therapy
|
|
US7648962B2
(en)
|
2002-11-26 |
2010-01-19 |
Biocon Limited |
Natriuretic compounds, conjugates, and uses thereof
|
|
ATE459370T1
(de)
*
|
2002-11-26 |
2010-03-15 |
Biocon Ltd |
Modifizierte natriuretic verbindungen, konjugate und ihre verwendungen
|
|
EP1582223A4
(en)
*
|
2003-01-10 |
2007-01-17 |
Niigata Tlo Corp |
VECTOR FOR GENE THERAPY AND METHOD FOR THE QUANTIFICATION OF A TARGET PROTEIN IN MAMMALIAN OR CULTURAL CELLS BY APPLYING THE VECTOR FOR GENE THERAPY
|
|
CN1819839B
(zh)
*
|
2003-01-29 |
2010-06-09 |
李惟 |
免疫调节化合物和相关方法
|
|
DE10316583A1
(de)
*
|
2003-04-10 |
2004-10-28 |
B.R.A.H.M.S Aktiengesellschaft |
Bestimmung eines midregionalen Proadrenomedullin-Teilpeptids in biologischen Flüssigkeiten zu diagnostischen Zwecken, sowie Immunoassays für die Durchführung einer solchen Bestimmung
|
|
JP2007523844A
(ja)
*
|
2003-04-25 |
2007-08-23 |
ジェノバ・リミテッド |
心臓血管障害において減少する分泌ポリペプチド種
|
|
PL1648933T3
(pl)
*
|
2003-07-25 |
2010-01-29 |
Conjuchem Biotechnologies Inc |
Długo działające pochodne insuliny i związane z tym sposoby
|
|
EP1789440A4
(en)
*
|
2004-02-11 |
2008-03-12 |
Amylin Pharmaceuticals Inc |
REASONS FOR THE FAMILY OF PANCREATIC POLYPEPTIDES AND POLYPEPTIDES CONTAINING THEM
|
|
JPWO2005090399A1
(ja)
*
|
2004-03-24 |
2008-05-08 |
財団法人岐阜県研究開発財団 |
各種細胞の増殖・分化を認識する抗体、その抗体を用いた増殖・分化の評価方法
|
|
WO2005103712A2
(en)
*
|
2004-04-20 |
2005-11-03 |
Sphingotec Gmbh |
Use of precursors of tachykinins and/or their fragments in medical diagnostic
|
|
ES2887039T3
(es)
|
2004-04-21 |
2021-12-21 |
Alexion Pharma Inc |
Conjugados para administración ósea y procedimiento de uso de estos para dirigir proteínas al hueso
|
|
PT2100904E
(pt)
|
2004-04-23 |
2010-09-24 |
Conjuchem Biotechnologies Inc |
Fase sólida para utilização num método para a purificação de conjugados de albumina
|
|
WO2005114222A1
(en)
*
|
2004-05-13 |
2005-12-01 |
Sphingo Tec Gmbh |
Use of precursors of enkephalins and/or their fragments in medical diagnostics
|
|
AU2012202855B2
(en)
*
|
2004-09-03 |
2015-02-26 |
Philipps-Universitat Marburg |
GLP-1 and exendin related invention
|
|
DE102004043153B4
(de)
*
|
2004-09-03 |
2013-11-21 |
Philipps-Universität Marburg |
Erfindung betreffend GLP-1 und Exendin
|
|
AU2005319578A1
(en)
|
2004-11-24 |
2006-06-29 |
Neopro Labs, Llc |
Methods and compositions for treating conditions
|
|
JP4720175B2
(ja)
*
|
2004-12-15 |
2011-07-13 |
富士ゼロックス株式会社 |
マレイミジル基含有材料およびその製造方法
|
|
DE102005003687A1
(de)
|
2005-01-26 |
2006-07-27 |
Sphingo Tec Gmbh |
Immunoassay zur Bestimmung der Freisetzung von Neurotensin in die Zirkulation
|
|
BRPI0607350A2
(pt)
|
2005-02-15 |
2009-09-01 |
Adlyfe Inc |
método para detecção da presença ou quantidade de uma proteìna erroneamente duplicada em uma amostra e kit
|
|
WO2006108686A2
(en)
*
|
2005-04-14 |
2006-10-19 |
Aic |
Bnp agonists
|
|
US7833979B2
(en)
*
|
2005-04-22 |
2010-11-16 |
Amgen Inc. |
Toxin peptide therapeutic agents
|
|
US20080292627A1
(en)
*
|
2005-05-05 |
2008-11-27 |
The Board Of Trustees Of The University Of Illinois |
Compositions and Methods for Treating Mood and Anxiety Disorders
|
|
US20100021480A1
(en)
*
|
2005-10-27 |
2010-01-28 |
Peptron Co., Ltd |
Bioactive substance-blood protein conjugate and stabilization of a bioactive substance using the same
|
|
WO2007112453A2
(en)
|
2006-03-28 |
2007-10-04 |
Neopro Labs, Llc |
Methods amd compositions for treating conditions
|
|
WO2008047241A2
(en)
|
2006-10-16 |
2008-04-24 |
Conjuchem Biotechnologies Inc. |
Modified corticotropin releasing factor peptides and uses thereof
|
|
WO2008052043A2
(en)
*
|
2006-10-24 |
2008-05-02 |
Cogenesys, Inc. |
Opioid receptor agonist fusion proteins
|
|
TW200833840A
(en)
*
|
2006-10-25 |
2008-08-16 |
Amgen Inc |
Toxin peptide therapeutic agents
|
|
KR101525754B1
(ko)
|
2007-03-28 |
2015-06-09 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
스티칭된 폴리펩티드
|
|
EP2152725A1
(en)
|
2007-05-17 |
2010-02-17 |
Neopro Labs, LLC |
Crystalline and amorphous forms of peptide
|
|
EP2738257A1
(en)
|
2007-05-22 |
2014-06-04 |
Amgen Inc. |
Compositions and methods for producing bioactive fusion proteins
|
|
WO2009023125A1
(en)
*
|
2007-08-14 |
2009-02-19 |
The Board Of Trustees Of The Leland Stanford Junior University |
Neuronostatin and its uses
|
|
WO2009039966A2
(en)
*
|
2007-09-11 |
2009-04-02 |
Mondobiotech Laboratories Ag |
Use of a peptide as a therapeutic agent
|
|
US20100190717A1
(en)
*
|
2007-09-11 |
2010-07-29 |
Dorian Bevec |
Use of melanin concentrating hormone and met-enkephalin as therapeutic agents
|
|
US20100184680A1
(en)
*
|
2007-09-11 |
2010-07-22 |
Dorian Bevec |
Therapeutic uses of b-type natriuretic peptide and human growth hormone 1-43
|
|
JP2011505335A
(ja)
*
|
2007-09-11 |
2011-02-24 |
モンドバイオテック ラボラトリーズ アクチエンゲゼルシャフト |
治療剤としてのＴＲＰ−６−トリプトレリンおよびＤ−Ｌｅｕ６−ロイプロリドの使用
|
|
EP2237799B1
(en)
|
2008-02-01 |
2019-04-10 |
Ascendis Pharma A/S |
Prodrug comprising a self-cleavable linker
|
|
US9242011B2
(en)
|
2008-04-01 |
2016-01-26 |
Novo Nordisk A/S |
Insulin albumin conjugates
|
|
WO2009142727A2
(en)
*
|
2008-05-19 |
2009-11-26 |
Vasogenix Pharmaceuticals, Inc. |
Sequence modified calcitonin gene related peptides (cgrp)
|
|
EP2546347A3
(en)
|
2009-02-25 |
2013-05-01 |
Merck Sharp & Dohme Corp. |
Glycoprotein composition from engineered galactose assimilation pathway in Pichia pastoris
|
|
WO2011013728A1
(ja)
*
|
2009-07-29 |
2011-02-03 |
第一三共株式会社 |
経粘膜吸収性を付与したモチリン類似ペプチド化合物
|
|
NZ598021A
(en)
|
2009-07-31 |
2014-05-30 |
Sanofi Aventis Deutschland |
Prodrugs comprising an insulin linker conjugate
|
|
MA33466B1
(fr)
|
2009-07-31 |
2012-07-03 |
Sanofi Aventis Deutschland |
Composition d'insuline à longue duree d'action
|
|
US8815806B2
(en)
|
2009-10-28 |
2014-08-26 |
University Of Manitoba |
Yellow pea seed protein-derived peptides
|
|
US8715963B2
(en)
|
2010-02-24 |
2014-05-06 |
Merck Sharp & Dohme Corp. |
Method for increasing N-glycosylation site occupancy on therapeutic glycoproteins produced in Pichia pastoris
|
|
EP2552950A1
(en)
*
|
2010-03-26 |
2013-02-06 |
Novo Nordisk A/S |
Novel glucagon analogues
|
|
CA2807685C
(en)
|
2010-08-13 |
2020-10-06 |
Aileron Therapeutics, Inc. |
P53 derived peptidomimetic macrocycle
|
|
EP2438930A1
(en)
|
2010-09-17 |
2012-04-11 |
Sanofi-Aventis Deutschland GmbH |
Prodrugs comprising an exendin linker conjugate
|
|
WO2012088608A1
(en)
|
2010-12-27 |
2012-07-05 |
Enobia Canada Limited Partnership |
Compositions comprising natriuretic peptides and methods of use thereof
|
|
CN104093735B
(zh)
|
2011-09-23 |
2018-07-06 |
诺沃—诺迪斯克有限公司 |
新的胰高血糖素类似物
|
|
TW201806968A
(zh)
|
2011-10-18 |
2018-03-01 |
艾利倫治療公司 |
擬肽巨環化合物
|
|
CA2864120A1
(en)
|
2012-02-15 |
2013-08-22 |
Aileron Therapeutics, Inc. |
Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
|
|
BR112014020103A2
(pt)
|
2012-02-15 |
2018-10-09 |
Aileron Therapeutics, Inc. |
macrociclos peptidomiméticos
|
|
JP2013179884A
(ja)
*
|
2012-03-01 |
2013-09-12 |
Mitsubishi Rayon Co Ltd |
メラニンカスケードに関与する成分を評価するための核酸マイクロアレイ及びメラニンカスケードに関与する成分の評価方法
|
|
CN108524919A
(zh)
|
2012-05-17 |
2018-09-14 |
延伸生物科学股份有限公司 |
用于改进的药物递送的载体
|
|
US10052366B2
(en)
|
2012-05-21 |
2018-08-21 |
Alexion Pharmaceuticsl, Inc. |
Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof
|
|
KR20150082307A
(ko)
|
2012-11-01 |
2015-07-15 |
에일러론 테라퓨틱스 인코포레이티드 |
이치환 아미노산 및 이의 제조 및 사용 방법
|
|
MY174727A
(en)
|
2013-04-18 |
2020-05-11 |
Novo Nordisk As |
Stable, protracted glp-1/glucagon receptor co-agonists for medical use
|
|
EP3016671B1
(en)
*
|
2013-07-04 |
2021-09-08 |
Universitat de Barcelona |
Actively transported and protease-resistant peptides as bbb shuttles and shuttle-cargo constructs
|
|
AU2015207776B2
(en)
*
|
2014-01-15 |
2017-06-15 |
Fyziologicky Ustav Akademie Ved Cr, V.V.I. |
Lipidated peptides for lowering blood glucose
|
|
EP3151852A1
(en)
|
2014-06-04 |
2017-04-12 |
Novo Nordisk A/S |
Glp-1/glucagon receptor co-agonists for medical use
|
|
WO2016007873A1
(en)
|
2014-07-11 |
2016-01-14 |
The Regents Of The University Of Michigan |
Compositions and methods for treating craniosynostosis
|
|
MX2017003797A
(es)
|
2014-09-24 |
2017-06-15 |
Aileron Therapeutics Inc |
Macrociclos peptidomimeticos y usos de los mismos.
|
|
WO2016065042A1
(en)
|
2014-10-22 |
2016-04-28 |
Extend Biosciences, Inc. |
Therapeutic vitamin d conjugates
|
|
US9616109B2
(en)
|
2014-10-22 |
2017-04-11 |
Extend Biosciences, Inc. |
Insulin vitamin D conjugates
|
|
US9789197B2
(en)
|
2014-10-22 |
2017-10-17 |
Extend Biosciences, Inc. |
RNAi vitamin D conjugates
|
|
BR112017011900A2
(pt)
|
2014-12-05 |
2018-02-27 |
Alexion Pharma Inc |
tratamento de ataques com fosfatase alcalina recombinante
|
|
CA2973883A1
(en)
|
2015-01-28 |
2016-08-04 |
Alexion Pharmaceuticals, Inc. |
Methods of treating a subject with an alkaline phosphatase deficiency
|
|
WO2016132359A2
(en)
*
|
2015-02-22 |
2016-08-25 |
Omnix Medical Ltd. |
Antimicrobial peptides
|
|
US10253067B2
(en)
|
2015-03-20 |
2019-04-09 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles and uses thereof
|
|
AU2016308624B2
(en)
|
2015-08-17 |
2022-06-23 |
Alexion Pharmaceuticals, Inc. |
Manufacturing of alkaline phosphatases
|
|
JP6868617B2
(ja)
|
2015-09-28 |
2021-05-12 |
アレクシオン ファーマシューティカルズ， インコーポレイテッド |
低ホスファターゼ血症の組織非特異的アルカリホスファターゼ（ｔｎｓａｌｐ）酵素補充療法に有効な投薬計画の特定
|
|
WO2017074466A1
(en)
|
2015-10-30 |
2017-05-04 |
Alexion Pharmaceuticals, Inc. |
Methods for treating craniosynostosis in a patient
|
|
US11530243B2
(en)
*
|
2016-02-18 |
2022-12-20 |
Veiove Animal Health Inc. |
Non-cleavable substance P conjugates and methods of use thereof
|
|
US11065306B2
(en)
|
2016-03-08 |
2021-07-20 |
Alexion Pharmaceuticals, Inc. |
Methods for treating hypophosphatasia in children
|
|
WO2017173395A1
(en)
|
2016-04-01 |
2017-10-05 |
Alexion Pharmaceuticals, Inc. |
Methods for treating hypophosphatasia in adolescents and adults
|
|
US11186832B2
(en)
|
2016-04-01 |
2021-11-30 |
Alexion Pharmaceuticals, Inc. |
Treating muscle weakness with alkaline phosphatases
|
|
US10988744B2
(en)
|
2016-06-06 |
2021-04-27 |
Alexion Pharmaceuticals, Inc. |
Method of producing alkaline phosphatase
|
|
JP7018933B2
(ja)
|
2016-08-18 |
2022-02-14 |
アレクシオン ファーマシューティカルズ， インコーポレイテッド |
気管気管支軟化症の治療方法
|
|
KR102368159B1
(ko)
|
2017-03-01 |
2022-03-03 |
청두 후타이 바이오메디슨 컴퍼니 리미티드 |
폴리펩티드, 폴리펩티드 단편, 그의 유도체, 및 그의 적용
|
|
CN110719786A
(zh)
|
2017-03-31 |
2020-01-21 |
阿雷克森制药公司 |
用于治疗成人和青少年的低磷酸酯酶症(hpp)的方法
|
|
US12297227B2
(en)
|
2017-06-02 |
2025-05-13 |
Mediford Corporation |
Method for extracting target protein from biological sample and method for analyzing target protein
|
|
CN109503700A
(zh)
*
|
2017-09-14 |
2019-03-22 |
南京安吉生物科技有限公司 |
马来酰亚胺基团修饰的血管生成抑制剂hm-1及其应用
|
|
US20210171598A1
(en)
|
2017-12-01 |
2021-06-10 |
University Of Copenhagen |
Peptide hormone with one or more o-glycans
|
|
US11913039B2
(en)
|
2018-03-30 |
2024-02-27 |
Alexion Pharmaceuticals, Inc. |
Method for producing recombinant alkaline phosphatase
|
|
WO2019197313A1
(en)
|
2018-04-09 |
2019-10-17 |
Svar Life Science Ab |
Glucagon Assay
|
|
EP3833377B1
(en)
|
2018-08-10 |
2023-11-22 |
Alexion Pharmaceuticals, Inc. |
Bone healing at implants using alkaline phosphatase
|
|
US20220073582A1
(en)
*
|
2018-12-31 |
2022-03-10 |
United Neuroscience Limited |
Peptide immunogens targeting calcitonin gene-related peptide (cgrp) and formulations thereof for prevention and treatment of migraine
|
|
MX2022007114A
(es)
|
2019-12-09 |
2022-07-11 |
Alexion Pharma Inc |
Polipeptidos de fosfatasa alcalina y metodos de uso de los mismos.
|
|
IT202000007720A1
(it)
*
|
2020-04-10 |
2021-10-10 |
Alessandra Marconi |
Peptidi e loro usi
|
|
CN116635027A
(zh)
*
|
2020-11-25 |
2023-08-22 |
普罗林科斯有限责任公司 |
C-利钠肽的延长释放水凝胶偶联物
|
|
BR112023016048A2
(pt)
|
2021-02-12 |
2023-11-14 |
Alexion Pharma Inc |
Polipeptídeos de fosfatase alcalina e métodos de uso dos mesmos
|
|
IL319526A
(en)
|
2022-09-30 |
2025-05-01 |
Extend Biosciences Inc |
Long-acting parathyroid hormone
|
|
GB202215797D0
(en)
|
2022-10-25 |
2022-12-07 |
Solasta Bio Ltd |
Insect neuropeptide analogues
|
|
US12302908B2
(en)
|
2023-10-23 |
2025-05-20 |
Solasta Bio Limited |
Insect neuropeptides 4
|
|
US12356995B2
(en)
|
2023-10-23 |
2025-07-15 |
Solasta Bio Limited |
Insect neuropeptides 9
|
|
US12279621B1
(en)
|
2023-10-23 |
2025-04-22 |
Solasta Bio Limited |
Insect neuropeptides 3
|
|
US12245588B1
(en)
|
2023-10-23 |
2025-03-11 |
Solasta Bio Limited |
Insect neuropeptides 2
|
|
US12281143B1
(en)
|
2023-10-23 |
2025-04-22 |
Solasta Bio Limited |
Insect neuropeptides 1
|
|
US12245596B1
(en)
|
2023-10-23 |
2025-03-11 |
Solasta Bio Limited |
Insect neuropeptides 8
|
|
WO2025196125A1
(en)
*
|
2024-03-19 |
2025-09-25 |
Epoqe Pharma Aps |
N-terminally modified calcitonin gene-related peptide analogues
|